S. Sodhi Rajwant's most recent trade in Tandem Diabetes Care Inc was a trade of 8,759 Restricted Stock Unit done . Disclosure was reported to the exchange on May 21, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Tandem Diabetes Care Inc | Rajwant S. Sodhi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 8,759 | 8,759 | - | - | Restricted Stock Unit | |
Tandem Diabetes Care Inc | Rajwant S. Sodhi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 4,387 | 0 | - | - | Restricted Stock Unit | |
Tandem Diabetes Care Inc | Rajwant S. Sodhi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.64 per share. | 21 May 2025 | 4,387 | 15,521 (0%) | 0% | 20.6 | 90,548 | Common Stock |
Tandem Diabetes Care Inc | Rajwant S. Sodhi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 4,434 | 0 | - | - | Restricted Stock Unit | |
Tandem Diabetes Care Inc | Rajwant S. Sodhi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.73 per share. | 22 May 2024 | 4,434 | 11,134 (0%) | 0% | 51.7 | 229,371 | Common Stock |
Tandem Diabetes Care Inc | Rajwant S. Sodhi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 4,387 | 4,387 | - | - | Restricted Stock Unit | |
Tandem Diabetes Care Inc | S. Sodhi Rajwant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.66 per share. | 04 Jan 2024 | 1,070 | 6,700 (0%) | 0% | 27.7 | 29,596 | Common Stock |
Tandem Diabetes Care Inc | Sodhi Rajwant S. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2024 | 1,070 | 0 | - | - | Restricted Stock Unit | |
Tandem Diabetes Care Inc | Rajwant S. Sodhi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 4,434 | 4,434 | - | - | RSU 2023 05 24 | |
Tandem Diabetes Care Inc | Rajwant S. Sodhi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 2,757 | 5,630 (0%) | 0% | 0 | Common Stock | |
Tandem Diabetes Care Inc | Rajwant S. Sodhi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 2,757 | 0 | - | - | Restricted Stock Unit | |
Tandem Diabetes Care Inc | Rajwant S. Sodhi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 1,069 | 2,873 (0%) | 0% | 0 | Common Stock | |
Tandem Diabetes Care Inc | Rajwant S. Sodhi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 1,069 | 1,070 | - | - | Restricted Stock Unit | |
Tandem Diabetes Care Inc | Rajwant S. Sodhi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 735 | 0 | - | - | Restricted Stock Unit | |
Tandem Diabetes Care Inc | Rajwant S. Sodhi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 735 | 1,804 (0%) | 0% | 0 | Common Stock | |
Tandem Diabetes Care Inc | Rajwant S. Sodhi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 1,069 | 1,069 (0%) | 0% | 0 | Common Stock | |
Tandem Diabetes Care Inc | Rajwant S. Sodhi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 1,069 | 2,139 | - | - | Restricted Stock Unit | |
ResMed | Rajwant Sodhi | President, SaaS Business | Sale of securities on an exchange or to another person at price $ 288.41 per share. | 01 Sep 2021 | 1,500 | 26,731 (0%) | 0% | 288.4 | 432,615 | ResMed Common Stock |
ResMed | Rajwant Sodhi | President, SaaS Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2021 | 4,066 | 28,231 (0%) | 0% | 0 | ResMed Common Stock | |
ResMed | Rajwant Sodhi S. | President, SaaS Business | Sale of securities on an exchange or to another person at price $ 269.00 per share. | 02 Aug 2021 | 1,500 | 24,165 (0%) | 0% | 269 | 403,500 | ResMed Common Stock |
ResMed | Rajwant Sodhi S. | President, SaaS Business | Sale of securities on an exchange or to another person at price $ 245.72 per share. | 01 Jul 2021 | 1,500 | 25,665 (0%) | 0% | 245.7 | 368,580 | ResMed Common Stock |
ResMed | Rajwant Sodhi S. | President, SaaS Business | Sale of securities on an exchange or to another person at price $ 207.13 per share. | 01 Jun 2021 | 1,500 | 27,165 (0%) | 0% | 207.1 | 310,695 | ResMed Common Stock |
Tandem Diabetes Care Inc | Rajwant Sodhi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 735 | 735 | - | - | Restricted Stock Unit | |
ResMed | Rajwant Sodhi S. | President, SaaS Business | Sale of securities on an exchange or to another person at price $ 190.50 per share. | 03 May 2021 | 1,500 | 28,588 (0%) | 0% | 190.5 | 285,750 | ResMed Common Stock |
ResMed | Rajwant Sodhi S. | President, SaaS Business | Sale of securities on an exchange or to another person at price $ 194.14 per share. | 01 Apr 2021 | 1,500 | 30,088 (0%) | 0% | 194.1 | 291,210 | ResMed Common Stock |
ResMed | Rajwant Sodhi S. | President, SaaS Business | Sale of securities on an exchange or to another person at price $ 194.34 per share. | 01 Mar 2021 | 1,500 | 31,588 (0%) | 0% | 194.3 | 291,510 | ResMed Common Stock |
ResMed | Rajwant Sodhi | President, SaaS Business | Sale of securities on an exchange or to another person at price $ 203.76 per share. | 01 Feb 2021 | 1,500 | 33,088 (0%) | 0% | 203.8 | 305,640 | ResMed Common Stock |
ResMed | Rajwant Sodhi S. | President, SaaS Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 1,913 | 34,588 (0%) | 0% | 0 | ResMed Common Stock | |
Tandem Diabetes Care Inc | Rajwant Sodhi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 3,208 | 3,208 | - | - | Restricted Stock Unit | |
ResMed | Rajwant Sodhi | President, SaaS Business | Sale of securities on an exchange or to another person at price $ 213.24 per share. | 04 Jan 2021 | 1,500 | 32,675 (0%) | 0% | 213.2 | 319,860 | ResMed Common Stock |
ResMed | Rajwant Sodhi | President, SaaS Business | Sale of securities on an exchange or to another person at price $ 210.46 per share. | 01 Dec 2020 | 1,500 | 34,175 (0%) | 0% | 210.5 | 315,690 | ResMed Common Stock |
ResMed | Rajwant Sodhi | President, SaaS Business | Grant, award, or other acquisition of securities at price $ 214.74 per share. | 17 Nov 2020 | 18,373 | 45,924 (0%) | 0% | 214.7 | 3,945,418 | ResMed Common Stock |
ResMed | Rajwant Sodhi | President, SaaS Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.74 per share. | 17 Nov 2020 | 10,249 | 35,675 (0%) | 0% | 214.7 | 2,200,870 | ResMed Common Stock |
ResMed | Rajwant Sodhi | President, SaaS Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 212.11 per share. | 11 Nov 2020 | 1,418 | 28,762 (0%) | 0% | 212.1 | 300,772 | ResMed Common Stock |
ResMed | Rajwant Sodhi | President, SaaS Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 212.11 per share. | 11 Nov 2020 | 1,211 | 27,551 (0%) | 0% | 212.1 | 256,865 | ResMed Common Stock |
ResMed | Rajwant Sodhi | President, SaaS Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 212.11 per share. | 11 Nov 2020 | 982 | 30,180 (0%) | 0% | 212.1 | 208,292 | ResMed Common Stock |
ResMed | Rajwant Sodhi | President, SaaS Business | Sale of securities on an exchange or to another person at price $ 195.16 per share. | 02 Nov 2020 | 1,500 | 31,089 (0%) | 0% | 195.2 | 292,740 | ResMed Common Stock |
ResMed | Rajwant Sodhi | President, SaaS Business | Sale of securities on an exchange or to another person at price $ 172.84 per share. | 01 Oct 2020 | 1,500 | 32,589 (0%) | 0% | 172.8 | 259,260 | ResMed Common Stock |
ResMed | Rajwant Sodhi | President, SaaS Business | Sale of securities on an exchange or to another person at price $ 181.00 per share. | 01 Sep 2020 | 1,500 | 34,089 (0%) | 0% | 181 | 271,500 | ResMed Common Stock |
ResMed | Rajwant Sodhi | President, SaaS Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2020 | 7,328 | 35,589 (0%) | 0% | 0 | ResMed Common Stock | |
ResMed | Rajwant Sodhi | President, SaaS Business | Sale of securities on an exchange or to another person at price $ 200.06 per share. | 03 Aug 2020 | 1,500 | 28,261 (0%) | 0% | 200.1 | 300,090 | ResMed Common Stock |